In MKN-45 GC cells and an MKN-45 xenografted tumour model, candesartan decreased the expression of transforming growth factor β1 (TGF-β1) and suppressed the EMT and fibrosis in tumours [80]. The gene discussed is TGFB1; the disease is neoplasm.